PDPL Intraday Analysis...

PDPL Share Price

Open 27.40 Change Price %
High 28.80 1 Day 1.20 4.54
Low 24.70 1 Week 4.80 21.01
Close 27.65 1 Month 5.45 24.55
Volume 526665 1 Year -9.60 -25.77
52 Week High 46.00
52 Week Low 19.30
PDPL Important Levels
Resistance 2 31.45
Resistance 1 29.88
Pivot 27.05
Support 1 25.42
Support 2 23.85
NSE INDIA Most Active Stocks
JPASSOCIAT 15.05 0.67%
GMRINFRA 15.45 7.67%
JINDALSTEL 100.15 7.69%
MARKSANS 48.60 20.00%
UNITECH 5.95 0.85%
RCOM 34.65 4.52%
IDEA 108.45 2.41%
FEDERALBNK 85.95 3.06%
SOUTHBANK 20.70 3.50%
JPPOWER 6.15 4.24%
More..
NSE INDIA Top Gainers Stocks
MARKSANS 48.60 20.00%
GOLDTECH 9.75 19.63%
PANACEABIO 158.35 19.33%
AUSTRAL 0.35 16.67%
IL&FSENGG 64.10 16.33%
DHARSUGAR 34.90 15.75%
UMANGDAIRY 84.45 14.59%
KAMATHOTEL 39.45 10.66%
VISASTEEL 22.45 10.59%
PEARLPOLY 30.45 10.53%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.10 -33.33%
VKSPL 0.10 -33.33%
HOTELRUGBY 4.00 -18.37%
LLOYDELENG 273.20 -16.59%
FCSSOFT 0.30 -14.29%
BLUECHIP 0.35 -12.50%
SRGINFOTEC 0.35 -12.50%
XLENERGY 2.85 -9.52%
ADHUNIK 7.85 -8.72%
GUJNREDVR 2.10 -8.70%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 2
As on 20th Feb 2017 PDPL Share Price closed @ 27.65 and we RECOMMEND Sell for LONG-TERM with Stoploss of 30.06 & Strong Buy for SHORT-TERM with Stoploss of 22.96 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for February
1st Target up-side 24.19
2nd Target up-side 25.42
3rd Target up-side 26.64
1st Target down-side 20.71
2nd Target down-side 19.48
3rd Target down-side 18.26
PDPL Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.